Nanogrow is a biotech company that builds an end-to-end nanobody bioengineering platform focused on discovering and developing next-gen biologics. We leverage VHH technology to overcome the limitations of traditional antibody-based medicines (mAbs), enabling localized delivery and high-affinity targeting in complex indications. 

Our platform specializes in single-domain antibodies (VHH), designed for superior tissue penetration and modular bioengineering compared to standard mAbs. We are advancing a robust R&D pipeline targeting high-unmet-need areas, including:
* Oncology: Solid tumors and specialized biologics.
* Inflammation & Immunology: Atopic dermatitis and Psoriasis.

With a dual presence in Montevideo (Uruguay) and Pamplona (Spain), we are scaling science to the global stage.

Nanogrow Biotech

Org chart

Teams

Offices